2009
DOI: 10.1590/s0100-879x2009001200003
|View full text |Cite
|
Sign up to set email alerts
|

Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
1
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 32 publications
2
1
0
Order By: Relevance
“…In fact, the first study done by Herrington et al (37) found a significant association between PvuII SNPs and treatment response to hormone therapy in terms of serum HDL with greater increase in serum HDL in women with PP genotype as compared to Pp or pp. Other small studies have found similar results (44,45). …”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…In fact, the first study done by Herrington et al (37) found a significant association between PvuII SNPs and treatment response to hormone therapy in terms of serum HDL with greater increase in serum HDL in women with PP genotype as compared to Pp or pp. Other small studies have found similar results (44,45). …”
Section: Discussionsupporting
confidence: 81%
“…These SNPs have previously been shown to be associated with bone markers (38), bone mineral density and fractures (39,40) and cardiovascular disease including myocardial infarction (41,42) and stroke (43). Few studies have examined the association of change in serum lipids in response to HT with estrogen receptor alpha gene SNPs (37, 44,45). …”
Section: Introductionmentioning
confidence: 99%
“…Apart from PPARα, another gene related to lipoprotein tissue related, APOB, showed a significantly downregulation upon ESR1 overexpression of [25]. Polymorphisms in ESR1 have been confirmed to be closely associated with human lipoprotein levels [26,27]. Our results demonstrated that the expression of PPARα and APOB significantly decreased in poGCs upon ESR1 overexpression.…”
Section: Discussionsupporting
confidence: 56%